Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells - ScienceDirect
Discovery and development of angiotensin receptor blockers - Wikipedia
Définitions et médicaments Flashcards | Quizlet
Protein Kinase C-Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference | Hypertension
Experimental and DFT characterization, antioxidant and anticancer activities of a Cu(II)–irbesartan complex: structure–antihypertensive activity relationships in Cu(II)–sartan complexes | SpringerLink
Molecules | Free Full-Text | Rational Drug Design and Synthesis of Molecules Targeting the Angiotensin II Type 1 and Type 2 Receptors | HTML
Clinical Experience With Angiotensin Receptor Blockers
Angiotensin II Receptor Blockers (ARBs): Indications, Side Effects, Mechanism of Action, Examples — EZmed
Sartan (irbesartan and losartan) related cluster. In total, 5 urine... | Download Scientific Diagram
Sartan Derivative - an overview | ScienceDirect Topics
sartans - antagonistedes récépeurs AT1 de l'angiotensine fmc
What can we expect from the binding characteristics of azilsartan, a newly available angiotensin II blocker, in hypertension? | Hypertension Research
Should Angiotensin II Receptor Blockers and Statins Be Combined? | Circulation
Sartan Derivative - an overview | ScienceDirect Topics
Should Angiotensin II Receptor Blockers and Statins Be Combined? | Circulation
Analysis of Sartans: A Review - Journal of Pharmaceutical Sciences
PPT - ANTIHYPERTENSEURS PowerPoint Presentation, free download - ID:862548
Sartan: What are sartans?
Angiotensin Receptor Blockers (ARBs) - Antihypertensive Agents - Cardiology for Medicine
Analysis of Sartans A Review | PDF | High Performance Liquid Chromatography | Spectrophotometry
